Instalab

Sesame Seed IgE Test

Find out whether your body treats sesame as a threat, before a reaction answers the question for you.

Should you take a Sesame Seed IgE test?

This test is most useful if any of these apply to you.

Reacted to Sesame or Tahini
This test checks whether your immune system makes the antibody behind allergic reactions to sesame.
Already Allergic to Peanuts or Tree Nuts
Sesame allergy overlaps frequently with nut allergies. This test clarifies your actual sesame risk.
Introducing Sesame to Your Child
Know whether your child's immune system is primed to react before the first taste.
Tracking Whether Your Child Is Outgrowing It
Declining levels over time signal possible tolerance. Serial testing shows the trajectory.

About Sesame Seed IgE

Sesame allergy can cause reactions ranging from hives to full anaphylaxis, and it is one of the food allergies least likely to be outgrown. A survey of over 78,000 U.S. households estimated that about 0.49% of the population has some form of sesame allergy, and roughly half of those have convincing evidence of an immune-mediated (IgE-driven) reaction. In countries where sesame consumption is high, like Israel, sesame ranks second only to cow's milk as a cause of severe allergic reactions in young children.

This blood test measures how much IgE (immunoglobulin E), the antibody class behind immediate allergic reactions, your body has made specifically against sesame proteins. A detectable level tells you that your immune system has been sensitized to sesame. But sensitization is not the same as allergy: some people carry sesame-specific IgE and eat sesame without symptoms. Understanding what your number means, and what it does not mean, is the difference between informed caution and unnecessary fear.

What Sesame-Specific IgE Actually Tells You

IgE antibodies are produced by a branch of your immune system that evolved to fight parasites but sometimes misfires against harmless proteins in food. When sesame-specific IgE is present, it sits on the surface of mast cells and basophils, two types of immune cells loaded with histamine and other inflammatory chemicals. If you eat sesame and its proteins encounter those armed cells, the cells can release their contents within minutes, causing the symptoms of an allergic reaction.

The standard lab test (ImmunoCAP) uses a water-based extract of whole sesame to capture your IgE. This picks up antibodies against many sesame proteins at once. A newer, more targeted approach measures IgE against a single protein called Ses i 1, a storage protein (belonging to a family called 2S albumins) that is strongly linked to true clinical sesame allergy. Your lab report will show results in kUA/L, a unit for allergen-specific IgE concentration.

How Accurate Is This Test?

A large meta-analysis pooling data from multiple studies found that whole-sesame extract IgE catches about 70% of truly allergic individuals (sensitivity) and correctly clears about 83% of non-allergic individuals (specificity). In children aged 2 to 16, sensitivity climbed to 94%. These are useful numbers, but they also mean the test misses some allergic people and falsely flags some tolerant ones.

Testing specifically for IgE against the Ses i 1 protein improves accuracy. In a study of 92 children, a Ses i 1 IgE cutoff of 3.96 kUA/L correctly identified 86.1% of allergic children and correctly cleared 85.7% of tolerant ones, a meaningful upgrade over whole-extract testing. When Ses i 1 IgE was combined with a basophil activation test (a specialized lab test that checks whether your immune cells actually fire when exposed to sesame), the combination correctly classified roughly 93% of children and cut the number needing an oral food challenge, the gold-standard test where you eat sesame under medical supervision, by about 75 to 80%.

Test TypeSensitivitySpecificity
Whole sesame extract IgEAbout 70% (up to 94% in children 2 to 16)About 83%
Ses i 1 component IgEAbout 77 to 86%About 86 to 87%
Basophil activation test (BAT)About 89%About 93%

These figures come from clinic-based pediatric populations referred for suspected sesame allergy. Performance may differ in adults or in populations with lower allergy prevalence.

Anaphylaxis and Reaction Severity

Sesame allergy is not a mild inconvenience for many who have it. Up to 70% of sesame-allergic patients in some cohorts have experienced anaphylaxis, the most severe form of allergic reaction involving difficulty breathing, a dangerous drop in blood pressure, or both. In Israel, sesame was the second most common trigger of anaphylaxis in infants and young children. Higher sesame-specific IgE levels and a higher ratio of sesame IgE to total IgE are associated with more severe reactions during supervised food challenges, though the test alone cannot predict exactly how bad a reaction will be.

If your level is elevated and you have a history of reactions to sesame-containing foods (tahini, hummus, certain breads, halvah), this test supports a real allergy. If your level is elevated but you have never reacted to sesame, you may be sensitized without being clinically allergic. The only way to know for certain is a supervised oral food challenge, which should be done in a medical setting equipped to treat a reaction.

Will You Outgrow It?

Most children with confirmed sesame allergy do not outgrow it. In one cohort followed for about five years, 82% still had persistent allergy. A separate study following children for six to seven years found that only about 20% developed tolerance. A larger retrospective analysis of 190 patients found spontaneous resolution in roughly one-third, but mainly in those whose first reaction was mild, whose skin prick test wheals were small (under 7 mm), and who did not also have tree nut allergy.

The direction of your sesame IgE over time matters more than any single reading. Children whose IgE levels and skin test reactions decreased over follow-up were far more likely to develop tolerance. Children whose levels stayed high or climbed were almost certainly going to remain allergic.

Interpreting Your Results

There is no single IgE number that definitively says "you are allergic" or "you are safe." The research shows a spectrum of probability, not a binary answer.

Sesame IgE LevelWhat It Suggests
Below 0.35 kUA/LIgE-mediated sesame allergy is very unlikely. In one pediatric study, no allergic child had a value this low.
0.35 to 7 kUA/LSensitization is present. Clinical significance depends on your history. Many people in this range tolerate sesame.
Above 7 kUA/LProbability of true allergy increases, but even at this level, the chance a positive result reflects true allergy was only about 74% in one cohort.
Above 20 kUA/LStrong sensitization. However, some peanut-allergic but sesame-tolerant children had values this high due to cross-reactivity.

These thresholds come from pediatric cohorts using ImmunoCAP whole-sesame extract. Your lab may report slightly different ranges. Always compare your results within the same lab over time rather than treating any single cutpoint as absolute.

Cross-Reactivity: Why Peanut Allergy Complicates the Picture

Sesame proteins share structural similarities with proteins in peanuts and tree nuts. In a cohort of U.S. children with IgE-mediated food allergies, about 16.6% also had sesame allergy, and most sesame-allergic children also had peanut or tree nut allergies. This overlap means that some elevated sesame IgE results are caused by cross-reactive antibodies originally made against peanut or tree nut proteins, not by a true immune response to sesame itself. If you are peanut-allergic and your sesame IgE is positive but you have never reacted to sesame, cross-reactivity is a real possibility and an oral food challenge may clarify your actual risk.

When Results Can Be Misleading

  • Cross-reactive IgE from peanut or tree nut allergy: Your immune system may produce antibodies that bind both peanut and sesame proteins. This can push your sesame IgE above the detection threshold even if you are not clinically allergic to sesame.
  • Oleosin-driven allergy missed by standard tests: Some sesame-allergic patients, including some with severe anaphylaxis, react to oil-body proteins called oleosins that are poorly represented in water-based test extracts. These individuals can have negative standard sesame IgE and negative skin tests despite genuine, sometimes dangerous, sesame allergy.
  • Very high total IgE: If your overall IgE is very high (common in severe eczema), low-level allergen-specific IgE results can be harder to interpret because a small fraction of your total IgE may non-specifically bind to the test.

Tracking Your Trend

A single sesame IgE reading is a snapshot. Because the test has moderate accuracy and your immune response can shift over months to years, serial measurements are far more informative. If your number is declining steadily over one to two years, especially alongside a shrinking skin prick test wheal, you may be developing tolerance and could be a candidate for a supervised food challenge. If your number is stable or rising, persistent allergy is more likely, and strict avoidance remains the safest strategy.

For children with confirmed sesame allergy, checking sesame IgE annually gives you a trajectory to work with. If you are making dietary changes, starting immunotherapy, or want to know whether you might be outgrowing the allergy, retest every 6 to 12 months. Always use the same lab and the same assay method so your numbers are directly comparable.

What to Do with an Abnormal Result

If your sesame IgE comes back elevated and you have a convincing history of reactions to sesame-containing foods, the result supports a diagnosis of sesame allergy. Your next steps should include consultation with an allergist, who can perform skin prick testing (ideally with both commercial extract and natural tahini for better sensitivity), consider Ses i 1 component testing if available, and determine whether a supervised oral food challenge is appropriate or too risky given your history.

If your sesame IgE is positive but you have no history of reacting to sesame, do not panic and do not eliminate sesame from your diet based on the blood test alone. Sensitization without clinical allergy is common. An allergist can help you decide whether a food challenge is warranted. If your sesame IgE is undetectable (below 0.35 kUA/L) and you have never reacted to sesame, IgE-mediated sesame allergy is very unlikely, though rare cases of oleosin-driven allergy can slip through standard testing.

What Moves This Biomarker

Evidence-backed interventions that affect your Sesame Seed IgE level

Up & Down
Sesame oral immunotherapy (OIT)
OIT involves eating small, gradually increasing amounts of sesame protein daily under medical supervision. Based on evidence from food allergen immunotherapy trials across multiple foods, allergen-specific IgE typically rises during the first weeks to months of treatment, then falls back to baseline or lower after 12 or more months. At the same time, allergen-specific IgG4 (a blocking antibody associated with tolerance) increases progressively. A randomized trial of low-dose sesame OIT in children (300 mg maintenance for 18 months) is underway, measuring sesame-specific IgE, IgG4, skin prick test, and basophil activation changes. Broader food OIT meta-analyses show that immunotherapy substantially raises the dose of food tolerated without reaction, but also increases the rate of allergic side effects, especially gastrointestinal symptoms, during treatment.
MedicationStrong Evidence
Decrease
Omalizumab (anti-IgE biologic) combined with oral immunotherapy
Omalizumab is an injectable medication that binds free IgE in your blood, reducing the amount available to trigger allergic reactions. When added to oral immunotherapy for IgE-mediated food allergies in children, omalizumab improved desensitization rates, allowed faster dose escalation, and reduced the frequency of allergic reactions during treatment compared to OIT alone. A meta-analysis found significantly higher desensitization rates with the combination. However, long-term durability of tolerance after stopping omalizumab remains uncertain, and this approach has been studied mainly for peanut, milk, and egg rather than sesame specifically.
MedicationModerate Evidence

Frequently Asked Questions

References

31 studies
  1. Riggioni C, Ricci C, Moya B, Wong DSH, Van Goor E, Bartha I, Buyuktiryaki B, Giovannini M, Jayasinghe S, Jaumdally H, Marques-mejias a, Piletta-zanin a, Berbenyuk a, Andreeva M, Levina D, Iakovleva E, Roberts G, Chu DK, Peters RL, Du Toit G, Skypala I, Santos AFAllergy2023
  2. Maruyama N, Nakagawa T, Ito K, Cabanos C, Borres M, Movérare R, Tanaka a, Sato S, Ebisawa MClinical & Experimental Allergy2016
  3. Goldberg M, Appel M, Nachshon L, Holmqvist M, Epstein-rigbi N, Levy M, Lidholm J, Elizur aPediatric Allergy and Immunology2021
  4. Zavalkoff S, Kagan R, Joseph L, St-pierre Y, Clarke aThe Journal of Allergy and Clinical Immunology2008
  5. Cohen a, Goldberg M, Levy B, Leshno M, Katz YPediatric Allergy and Immunology2007